SAM
PRQR icon

Sectoral Asset Management’s ProQR Therapeutics PRQR Stock Holding History

Sectoral Asset Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-70,000
Closed -$1.2M – 70
2014
Q3 		$1.2M Buy
+70,000
New +$1.12M 0.05% 61

Other funds holding PRQR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

Sectoral Asset Management's PRQR Position: Q4 2014 in Review

Sectoral Asset Management sold out of ProQR Therapeutics (PRQR) in Q4 2014, closing a stake of 70,000 shares — an estimated $1.2M sold.

Sectoral Asset Management first reported a position in PRQR in Q3 2014 and held it in 1 quarter. The position peaked at $1.2M in Q3 2014. 35 funds tracked by Wall St. Rank hold PRQR as of Q4 2014.

  • Sectoral Asset Management reported no remaining ProQR Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Sectoral Asset Management sold 70,000 ProQR Therapeutics shares in Q4 2014, an estimated $1.2M.
  • Sectoral Asset Management first reported a position in ProQR Therapeutics in Q3 2014 and held it in 1 quarter.
  • Sectoral Asset Management's ProQR Therapeutics position peaked at $1.2M in Q3 2014.
  • 35 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2014.

Based on Sectoral Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.